Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CRISPR/Cas9 and Genome Editing for Viral Disease-Is Resistance Futile?

ACS infectious diseases - 8 Jun 2018

De Silva Feelixge Harshana S, Stone Daniel, Roychoudhury Pavitra, Aubert Martine, Jerome Keith R

Abstract excerpt

Chronic viral infections remain a major public health issue affecting millions of people worldwide. Highly active antiviral treatments have significantly improved prognosis and infection-related morbidity and mortality but have failed to eliminate persistent viral forms. Therefore, new strategies to either eradicate or control these viral reservoirs are paramount to allow patients to stop antiretroviral therapy...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Combined Modality Therapy
Share to Carrier State
Share to CRISPR-Cas Systems

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gene Editing

Share to Quasispecies

Share to RNA, Guide, CRISPR-Cas Systems

Share to Virus Diseases

Share to Viruses

Source

Open in PubMed Open full text

Identifiers

PMID: 29522311
DOI: 10.1021/acsinfecdis.7b00273
PMCID: PMC5993632

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CRISPR/Cas9 and Genome Editing for Viral Disease-Is Resistance Futile?PMID 29522311Read ↗

CRISPR/Cas9-Derived Mutations Both Inhibit HIV-1 Replication and Accelerate Viral Escape.Semantic proximity Read ↗

Elimination of infectious HIV DNA by CRISPR–Cas9Semantic proximity Read ↗

CRISPR-Cas based antiviral strategies against HIV-1Semantic proximity Read ↗

CRISPR-Cas9 Can Inhibit HIV-1 Replication but NHEJ Repair Facilitates Virus Escape.Semantic proximity Read ↗

A combinational CRISPR/Cas9 gene-editing approach can halt HIV replication and prevent viral escapeSemantic proximity Read ↗

Harnessing CRISPR to combat human viral infectionsSemantic proximity Read ↗

A Combinatorial CRISPR-Cas9 Attack on HIV-1 DNA Extinguishes All Infectious Provirus in Infected T Cell Cultures.Semantic proximity Read ↗

Current Challenges With Highly Active Antiretroviral Therapy and New Hope and Horizon With CRISPR ‐ CAS9 Technology for HIV TreatmentSemantic proximity Read ↗

CRISPR/Cas9: a tool to eradicate HIV-1Semantic proximity Read ↗

CRISPR/Cas9-Based Antiviral Strategy: Current Status and the Potential ChallengeSemantic proximity Read ↗

Host Double Strand Break Repair Generates HIV-1 Strains Resistant to CRISPR/Cas9.Semantic proximity Read ↗

The therapeutic application of CRISPR/Cas9 technologies for HIVSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.